A case of refractory IgG4-related disease successfully treated with daratumumab and lenalidomide

Journal Article Accepted manuscript A case of refractory IgG4-related disease successfully treated with daratumumab and lenalidomide Get access Denis Coulomb, Denis Coulomb Department of Clinical Hematology, CHU de Montpellier, Montpellier, France Search for other works by this author on: Oxford Academic PubMed Google Scholar Vanessa Szablewski, Vanessa Szablewski Department of Pathology, CHU de Montpellier, Montpellier, France Search for other works by this author on: Oxford Academic PubMed Google Scholar Nicolas Robert, Nicolas Robert Department of Biological Hematology, CHU de Montpellier, Montpellier, France Search for other works by this author on: Oxford Academic PubMed Google Scholar Anne-Marie Dupuy, Anne-Marie Dupuy Department of Biochemistry, CHU de Montpellier, Montpellier, France Search for other works by this author on: Oxford Academic PubMed Google Scholar Rayane Berrahouane, Rayane Berrahouane Department of Clinical Hematology, CHU de Montpellier, Montpellier, France Search for other works by this author on: Oxford Academic PubMed Google Scholar Radjiv Goulabchand, Radjiv Goulabchand Desbrest Institute of Epidemiology and Public Health, University of Montpellier and INSERM, Montpellier, France Search for other works by this author on: Oxford Academic PubMed Google Scholar Jérôme Moreaux, Jérôme Moreaux Department of Biological Hematology, CHU de Montpellier, Montpellier, FranceUMR CNRS-UM 9002, Institute of Human Genetics, Montpellier, FranceInstitut Universitaire de France (IUF), Paris, France Search for other works by this author on: Oxford Academic PubMed Google Scholar Alexandre Thibault Jacques Maria, Alexandre Thibault Jacques Maria Department of Internal Medicine & Onco-Immunology (MedI2O), CHU de Montpellier, Montpellier, FranceInstitute for Regenerative Medicine and Biotherapy (IRMB), University of Montpellier, Montpellier, France Search for other works by this author on: Oxford Academic PubMed Google Scholar Charles Herbaux Charles Herbaux Department of Clinical Hematology, CHU de Montpellier, Montpellier, FranceUMR CNRS-UM 9002, Institute of Human Genetics, Montpellier, France Corresponding author: Pr Charles Herbaux MD, PhD, Department of Clinical Hematology—CHU de Montpellier & Institute of Human Genetics, UMR 9002—CNRS, University of Montpellier, School of Medicine, Montpellier, France, Email: c-herbaux@chu-montpellier.fr Search for other works by this author on: Oxford Academic PubMed Google Scholar Rheumatology, keae448, https://doi.org/10.1093/rheumatology/keae448 Published: 24 August 2024 Article history Received: 06 June 2024 Revision received: 10 July 2024 Accepted: 08 August 2024 Published: 24 August 2024